Proteon Pharmaceuticals Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
83
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$44.3K
- Investors
-
11
Proteon Pharmaceuticals General Information
Description
Developer of a microbiome using bacteriophage-based products designed to improve animal and human health. The company's products in livestock farming and aquaculture reduce the need for antibiotics and the risk posed by antimicrobial resistance, enabling clients to prevent infections caused by bacteria improve performance, and increase sustainability.
Contact Information
Website
www.proteonpharma.comCorporate Office
- Ulica Tylna 3A
- Lodz, 90-364
- Poland
Corporate Office
- Ulica Tylna 3A
- Lodz, 90-364
- Poland
Proteon Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 09-Nov-2022 | $44.3K | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series B) | 10-Aug-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 01-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 24-Oct-2017 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2016 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2014 | Completed | Generating Revenue | |||
| 2. Grant | 01-Nov-2012 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Jan-2008 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Proteon Pharmaceuticals Comparisons
Industry
Financing
Details
Proteon Pharmaceuticals Competitors (3)
One of Proteon Pharmaceuticals’s 3 competitors is Intralytix, a Corporate Backed or Acquired company based in Baltimore, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intralytix | Corporate Backed or Acquired | Baltimore, MD | ||||
| Micreos Group | Venture Capital-Backed | Bilthoven, Netherlands | ||||
| Phagelux | Private Equity-Backed | Nanjing, China |
Proteon Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Proteon Pharmaceuticals Patents
Proteon Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022259360-A1 | A bacteriophage preparation in the form of gel to prevent or treat bacterial infections in dairy cattle, its manufacturing method and bacteriophage strains | Inactive | 11-Apr-2021 | ||
| CA-3215008-A1 | A bacteriophage preparation in the form of gel to prevent or treat bacterial infections in dairy cattle, its manufacturing method and bacteriophage strains | Pending | 11-Apr-2021 | ||
| EP-4322966-A2 | A bacteriophage preparation in the form of gel to prevent or treat bacterial infections in dairy cattle, its manufacturing method and bacteriophage strains | Pending | 11-Apr-2021 | ||
| WO-2022220699-A2 | A bacteriophage preparation in the form of gel to prevent or treat bacterial infections in dairy cattle, its manufacturing method and bacteriophage strains | Inactive | 11-Apr-2021 | ||
| WO-2022220699-A3 | A bacteriophage preparation in the form of gel to prevent or treat bacterial infections in dairy cattle, its manufacturing method and bacteriophage strains | Inactive | 11-Apr-2021 | A61P31/04 |
Proteon Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Proteon Pharmaceuticals Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Blue Bio Value | Accelerator/Incubator | Minority | ||
| Montis Capital (Warsaw) | Venture Capital | Minority | ||
| Newtree Impact | Venture Capital | Minority | ||
| Nutreco | Corporation | Minority | ||
| PFR Life Science | Venture Capital | Minority |
Proteon Pharmaceuticals FAQs
-
When was Proteon Pharmaceuticals founded?
Proteon Pharmaceuticals was founded in 2005.
-
Where is Proteon Pharmaceuticals headquartered?
Proteon Pharmaceuticals is headquartered in Lodz, Poland.
-
What is the size of Proteon Pharmaceuticals?
Proteon Pharmaceuticals has 83 total employees.
-
What industry is Proteon Pharmaceuticals in?
Proteon Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Proteon Pharmaceuticals a private or public company?
Proteon Pharmaceuticals is a Private company.
-
What is Proteon Pharmaceuticals’s current revenue?
The current revenue for Proteon Pharmaceuticals is .
-
How much funding has Proteon Pharmaceuticals raised over time?
Proteon Pharmaceuticals has raised $29M.
-
Who are Proteon Pharmaceuticals’s investors?
Blue Bio Value, Montis Capital (Warsaw), Newtree Impact, Nutreco, and PFR Life Science are 5 of 11 investors who have invested in Proteon Pharmaceuticals.
-
Who are Proteon Pharmaceuticals’s competitors?
Intralytix, Micreos Group, and Phagelux are competitors of Proteon Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
